You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Natera, Inc. v. NeoGenomics Laboratories, Inc. (Fed. Cir. 2024)

✉ Email this page to a colleague

« Back to Dashboard

Natera, Inc. v. NeoGenomics Laboratories, Inc. (Fed. Cir. 2024)

Docket	⤷ Sign Up	Date Filed	2024-01-04
Court	Court of Appeals for the Federal Circuit	Date Terminated
Cause		Assigned To
Jury Demand		Referred To
Parties	NATERA, INC.
Patents	6,807,491; 7,981,609; 8,389,578
Attorneys	Seth W. Lloyd
Firms	Direct: 202-556-2011, MoloLamken LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in Natera, Inc. v. NeoGenomics Laboratories, Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Biologic Drugs cited in Natera, Inc. v. NeoGenomics Laboratories, Inc.

The biologic drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Natera, Inc. v. NeoGenomics Laboratories, Inc. (Fed. Cir. 2024)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2024-02-09	20		continuation-in-part of application No. 13/110,685, 6,807,491 B2 10/2004 Pavlovic et al. filed… method patents. Patent No. 11,519,035 issued on December 6, 2022, Doc. 1-2 at 2, and Patent No. 11,530,454…the ’454 patent in Natera, Inc. v. Inivata, Inc., 1:22-cv-01609 (D. Del.). The same patent is also currently… assessing Natera’s patent, both on invalidity and infringement. Natera’s patent, with an alleged 2011…Despite that narrow patent description, the much-later-drafted claims of the ’035 patent generically recite	External link to document
2024-03-18	42		continuation-in-part of application No. 13/110,685, 6,807,491 B2 10/2004 Pavlovic et al. filed…10,081,839 B2 9/2018 Rabinowitz et al. 6,807,491 B2 10/2004 Pavlovic et al. … method patents. Patent No. 11,519,035 issued on December 6, 2022, Doc. 1-2 at 2, and Patent No. 11,530,454…Natera’s U.S. Patent Nos. 11,530,454 (the “’454 Patent”) and 11,519,035 (the “’035 Patent”) (collectively…7. Among these patented inventions include the ’454 Patent and the ’035 Patent, each of which Defendant	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.